Announcements Trials
Browse Landscape

Phase

Phase 2 32Phase 3 20Phase 1 16Phase 1/2 6Phase NA 2Phase 2/3 1

Status

Completed 38Terminated 21Recruiting 18Unknown 11Withdrawn 9Active not recruiting 6Not yet recruiting 4Suspended 1

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 5Breast 1

Conditions

Pancreatic Neoplasms 3TNBC 1Neoplasm Metastasis 1Metastatic Pancreatic Ductal Adenocarcinoma 1Anal Cancer Metastatic 1

Interventions

pembrolizumab 70Nivolumab 36Cyclophosphamide 34Carboplatin 28Dexamethasone 23Specimen Handling 22Paclitaxel 22Lenalidomide 22durvalumab 20venetoclax 19Radiotherapy 19Gemcitabine 19Magnetic Resonance Spectroscopy 18Doxorubicin 17Rituximab 16fludarabine 15Ipilimumab 15Bevacizumab 15Cisplatin 14Biopsy 14atezolizumab 13Etoposide 13Vincristine 12Pemetrexed 12Azacitidine 12belantamab mafodotin 11Docetaxel 11Calcium Dobesilate 11olaparib 10Oxaliplatin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Active not recruiting × 130-nm albumin-bound paclitaxel × Clear all
NCT07280377 2026-05-19

GOBLET

Oncolytics Biotech

Phase 1/2 Active not recruiting
122 enrolled
Gastrointestinal

Anal Cancer Metastatic

NCT06646055 2026-03-09

AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer

Akeso

Phase 1/2 Active not recruiting
110 enrolled
Gastrointestinal

Metastatic Pancreatic Ductal Adenocarcinoma

NCT02481635 2025-12-08

A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer

University Health Network, Toronto

Phase 1/2 Active not recruiting
30 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04821284 2025-11-04

Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer

Thomas Jefferson University

Phase 1/2 Active not recruiting
120 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT05669482 2025-09-02

RAMP205

Verastem, Inc.

Phase 1/2 Active not recruiting
40 enrolled
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT05918133 2025-03-11

A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC

Biotheus Inc.

Phase 1/2 Active not recruiting
42 enrolled
Breast

TNBC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡